
Credent Connect N Care IPO
- Issue price
- ₹189
- Listing price
- ₹359.1
- +90.00%
- Current price
- ₹409
- +116.40%
- Subscribed
- 142.38x
- Issue size
- ₹93.9 Cr
- Listed on
- 20 Aug 2026
IPO timeline
- Opens13 AugThu
- Closes17 AugMon
- Allotment18 AugTue
- Refunds19 AugWed
- Demat credit19 AugWed
- Listing20 AugThu
Issue details
- Price band
- ₹179 – ₹189 per share
- Issue size
- ₹93.9 Cr
- Fresh issue
- ₹93.9 Cr · 0.5 Cr shares
- Offer for sale
- None
- Issue type
- Fresh capital only
- Face value
- ₹10 per share
- Lot size
- 600 shares
- Minimum investment
- ₹1,13,400
- Listing on
- NSE SME
- Exchange code
- CREDENT-SM · CREDENT
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 600 | ₹1,13,400 |
| Retail (Max) | 1 | 600 | ₹1,13,400 |
| HNI (Min) | 2 | 1,200 | ₹2,26,800 |
Reservation
- QIB
- 9,48,000 shares
- NII
- 7,08,000 shares (21.38% of the Offer)
- Retail
- 16,56,000 shares (50.00% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on KFin Technologies- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 18 Aug 2026
- Refunds initiated
- 19 Aug 2026
- Shares credited to demat
- 19 Aug 2026
- Listing
- 20 Aug 2026
Grey market premium (GMP)
- Current GMP
- ₹92
- +48.68%
- Estimated listing price
- ₹281
- Issue price ₹189
- Highest
- ₹92
- 20 Aug
- Lowest
- ₹35
- 11 Aug
GMP by day (₹ per share)
Day-wise GMP table
| Date | GMP | Premium | Est. listing |
|---|---|---|---|
| 20 Aug 2026 | ₹92 | +48.68% | ₹281 |
| 19 Aug 2026 | ₹91 | +48.15% | ₹280 |
| 18 Aug 2026 | ₹63 | +33.33% | ₹252 |
| 17 Aug 2026 | ₹45 | +23.81% | ₹234 |
| 16 Aug 2026 | ₹55 | +29.10% | ₹244 |
| 15 Aug 2026 | ₹55 | +29.10% | ₹244 |
| 14 Aug 2026 | ₹65 | +34.39% | ₹254 |
| 13 Aug 2026 | ₹75 | +39.68% | ₹264 |
| 12 Aug 2026 | ₹50 | +26.46% | ₹239 |
| 11 Aug 2026 | ₹35 | +18.52% | ₹224 |
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB130.4x
- NII (HNI)160.28x
- Retail138.86x
| Category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| Qualified Institutional Buyers (QIB) | 9,48,000 | 12,36,15,600 | 130.4x |
| Non-Institutional Investors (NII) | 9,60,000 | 15,38,67,000 | 160.28x |
| bNII — bids above ₹10 Lakh | 6,40,000 | 12,08,84,400 | 188.88x |
| sNII — bids ₹2 Lakh to ₹10 Lakh | 3,20,000 | 3,29,82,600 | 103.07x |
| Retail Individual Investors (RII) | 16,56,000 | 22,99,52,400 | 138.86x |
| Total | 35,64,000 | 50,74,35,000 | 142.38x |
Financials
- P/E Ratio
- 18.68
- EPS (₹)
- 10.12
- RoCE
- 16.96%
- RoNW
- 14.13%
- PAT Margin
- 2.88%
Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.
| Period ended | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|
| Assets | 29.50 | 26.41 |
| Total Income | 78.23 | 76.02 |
| Profit After Tax | 2.25 | 2.66 |
| EBITDA | 4.99 | 4.30 |
| NET Worth | 15.90 | 13.66 |
| Reserves and Surplus | 15.70 | 13.46 |
| Total Borrowing | 7.42 | 6.85 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Credent Connect N Care This IPO | ₹93.9 Cr | 18.68 | 14.13% | 2.88% | 142.38x | +90.00% |
| Pramodini Medicare SME · listed 19 Aug 2026 | ₹69.04 Cr | 14.97 | 32.69% | 27.90% | 3.66x | +1.69% |
| Bio Medica Laboratories SME · listed 29 May 2026 | ₹52 Cr | 13.45 | 99.59% | 25.64% | 2.31x | -20.00% |
| ABH Healthcare SME · listed 1 Sep 2026 | ₹34.98 Cr | 20.69 | 39.07% | 10.74% | 1.42x | -2.94% |
| Q-Line Biotech SME · listed 29 May 2026 | ₹251 Cr | — | — | — | 102.49x | +31.78% |
| Avience Biomedicals SME · listed 25 Jun 2026 | ₹30.24 Cr | 16.56 | 49.89% | 15.86% | 385.4x | +90.00% |
| Speciality Medicines SME · listed 30 Mar 2026 | ₹29 Cr | 10.49 | 28.30% | 14.77% | 2.19x | 0.00% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
IPO objectives
How Credent Connect N Care plans to use the money raised, as stated in the offer document.
- Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to meet its working capital requirement₹26.8 Cr
- Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to finance its capital expenditure requirements for machinery₹3 Cr
- To meet Working Capital Requirements₹37 Cr
- Repayment and/or repayment, in full or part, of borrowing availed by the Company₹6 Cr
- General corporate purposes
About Credent Connect N Care
Credent Connect N Care Limited was started in June 2015 as Credent Cold Chain Logistics Private Limited. The company provides healthcare support services and healthcare logistics. It works mainly on a B2B basis, that is it serves other businesses such as diagnostic laboratories, IVD companies, pharma companies, hospitals and clinics, and not patients directly. Its services include home sample collection through trained phlebotomists, supplying laboratory and phlebotomy manpower to hospitals, diagnostic and paramedical services, healthcare logistics, and corporate wellness programmes. Its logistics work covers movement of test samples, medical supplies and reagents in temperature controlled and time bound conditions, including cold chain transport. It also runs a courier aggregation platform called C3 Post and a corporate wellness business under the C3 Wellness brand which does health camps, vaccination drives and preventive health check ups. The company works across India through warehouses, branch offices, its own vehicles and field staff. It has grown partly through acquisitions, including Credent Healthcare Private Limited, Credent Team Private Limited and Alltrak Technologies Private Limited. It holds ISO 9001:2015 and ISO 15189:2022 certification. As on 31 March 2026 it had 6,338 people working with it, of which 4,052 were on its payroll and 2,286 were on contract.
Strengths
- The company offers logistics, manpower, diagnostics support and wellness services together, so a hospital or lab can get several needs met from one vendor.
- It works pan India through warehouses, branch offices, its own vehicles and field staff, which is difficult for a new competitor to build quickly.
- Cold chain and time bound transport of test samples is a specialised job and needs proper systems, which acts as an entry barrier.
- The B2B model with laboratories and hospitals gives repeat and contract based business rather than one time sales.
- It has built technology platforms of its own such as C3 Post for courier aggregation and C3 HRMS for managing its large workforce.
- The company holds ISO 9001:2015 and ISO 15189:2022 certification, the second one being specific to medical laboratories.
- Net worth improved from Rs 13.66 crore to Rs 15.90 crore and EBITDA from Rs 4.30 crore to Rs 4.99 crore between FY2024 and FY2025.
- Rs 29.80 crore of the issue money goes into its wholly owned subsidiary Credent Healthcare for working capital and machinery.
Risks
- Profit fell in the latest year shown in the offer document. Profit after tax came down from Rs 2.66 crore in FY2024 to Rs 2.25 crore in FY2025, even though income rose slightly from Rs 76.02 crore to Rs 78.23 crore.
- The margin is very thin. Profit after tax of Rs 2.25 crore on total income of Rs 78.23 crore works out to under 3%.
- The issue size of Rs 93.90 crore is large compared to the size of the business. Net worth was only Rs 15.90 crore and profit only Rs 2.25 crore as on 31 March 2025.
- This is a people heavy business. It runs with 6,338 workers for about Rs 78 crore of income, so any rise in wages directly eats into the small margin.
- More than a third of the workforce, 2,286 out of 6,338, is on contract, which brings attrition and compliance risk.
- The company has grown through acquisitions of three companies. Merging different businesses does not always work out as planned.
- Rs 37.00 crore of the money is for its own working capital, which shows that a lot of money stays blocked in receivables from hospitals and labs.
- This is an SME issue. One lot is 600 shares, which is about Rs 1.13 lakh at the upper band of Rs 189, and SME shares usually trade in low volume after listing.
Promoters and shareholding
Ashok Kumar Sharma, Karan Sharma, Tarun Sharma, Dimple Sharma and Tanveen
- Promoter holding, pre-issue
- 87.64%
- Promoter holding, post-issue
- 63.75%
Registrar, lead managers and documents
Lead manager
Company contact
B-3, Second Floor, Nimri Commercial Complex, Ashok Vihar, Phase-4, Delhi, New Delhi, 110052
+91-9971777199
cs@c3logistics.co.inDocuments
Credent Connect N Care IPO: common questions
1.When does the Credent Connect N Care IPO open and close?
The Credent Connect N Care IPO opens on 13 Aug 2026 and closes on 17 Aug 2026.
2.What is the price band of the Credent Connect N Care IPO?
The price band is ₹179 – ₹189 per share, with a lot size of 600 shares and a minimum investment of ₹1,13,400.
3.What is the size of the Credent Connect N Care IPO?
The issue size is ₹93.9 Cr (Fresh capital only).
4.What is the GMP of the Credent Connect N Care IPO?
The last reported grey market premium is ₹92 per share as of 20 Aug 2026, 08:24 AM IST. GMP is unofficial and changes frequently.
5.When is the Credent Connect N Care IPO allotment?
The basis of allotment is expected on 18 Aug 2026. Allotment status can be checked with the registrar, KFin Technologies Limited.
6.When will the Credent Connect N Care IPO list?
The shares listed on 20 Aug 2026 on NSE SME.
7.Who is the lead manager of the Credent Connect N Care IPO?
The book running lead manager is Hem Securities Ltd., and the registrar is KFin Technologies Limited.
8.What will the money raised in the Credent Connect N Care IPO be used for?
As stated in the offer document, the proceeds are for: Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to meet its working capital requirement; Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to finance its capital expenditure requirements for machinery; To meet Working Capital Requirements; Repayment and/or repayment, in full or part, of borrowing availed by the Company; General corporate purposes.
9.How can my company launch an IPO like Credent Connect N Care?
Start with an IPO readiness assessment: eligibility for the NSE Emerge or BSE SME platform, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393